A pivotal step forward for Duchenne families as gene therapy shows promise to transform neuromuscular care.
A pivotal step forward for Duchenne families as gene therapy shows promise to transform neuromuscular care.
A historic breakthrough as the first CRISPR-based gene-editing therapy gains FDA approval, offering new hope for sickle cell …
Already a subscriber? Log in